Tuesday, 23 August 2016

REMEDY FOR A BROKEN HEART – SCIENTISTS GROW A BEATING HUMAN HEART IN A LAB

Scientist have for long been researching the employment of stem cells to cure heart diseases.

Heart disease claims more than 17 million deaths worldwide every year making it the biggest cause of death. Congenital heart defects, heart attacks and alcoholism/drug abuse continually damage the heart. While most defects gradually weaken the heart over time, heart attacks may sometimes result in sudden and detrimental damage to the heart. Damage is not limited to a specific type of cells and, thus, cannot be alleviated with simple measure. Some of the most important types of cells in the heart include cardiomyocytes (muscle cells that make the heart beat), cardiac pacemaker cells (that send and receive electrical signals to maintain rhythm) and endothelial cells (which line the blood vessels to help deliver oxygen to cardiomyocytes).

physicians

Repairing the damage to the heart would require renovation of all cell types which is an incredibly difficult feat to pull off.

This is where stem cells come in!

Stem cells have the ability to transform into different types of cells. For long now, scientists have been dreaming of creating transplantable hearts from stem cells in a lab and a group of researchers have just brought themselves one step closer to that dream by growing a beating human heart in a lab. They used pluripotent stem cells to create all types of heart cells over what they called a “scaffold” foundation.

Here is the full report by Robin Andrews from IFL Science

Right now, there are 4,186 people waiting for a heart transplant in the U.S., but with a huge donor shortage not all of these patients are likely to survive. Growing transplantable hearts in a laboratory has been a long-standing dream within the medical community, and a study in the journal Circulation Research has moved it one step closer to reality: A team of researchers have successfully grown a beating human heart in the laboratory using stem cells.

patients

Previous research has shown how 3D printers can be used to manufacture 3D heart segments using biological material. Although vacant of any actual heart cells, these structures provided the “scaffold” on which heart tissue could be grown. Now, a team from both Massachusetts General Hospital (MGH) and Harvard Medical School has taken this scaffolding concept and combined it with stem cells for some truly spectacular results.

The main problem with heart transplants, other than a lack of donors, is that there’s a chance that the receiver’s body will reject the new organ. Their immune system will often register the foreign tissue as a threat, whereupon it will proceed to attack and destroy it. The only way to stop this from happening are drugs that suppress the immune system, and this is only successful in some cases.

For this study, 73 human hearts deemed unsuitable for transplantation were carefully immersed in solutions of detergent in order to strip them of any cells that would provoke this self-destructive response. What was left was a matrix (or “scaffold”) of a heart, complete with its intricate structures and vessels, providing a new foundation for new heart cells to be grown onto.

This is where pluripotent stem cells come in. These “primitive” stem cells have the ability to become almost any type of cell in the body, including bone, nerve, and even muscle – including those found in the heart.

about-stem-cell-therapy

For this research, human skin cells were reprogrammed into becoming pluripotent stem cells. They were then induced into becoming two types of heart cells, which were shown to readily develop and grow on the lab scaffold when bathed in a nutrient solution.

After just two weeks, the networks of lab-grown heart cells already resembled immature but intricately structured hearts. The team gave them a burst of electricity, and the hearts actually started beating.

Significantly, any heart cells grown in this way would be recognized by the patient’s immune system as “friendly,” as long as the original skin cells were sourced from their own body in the first place. This means that these lab-grown hearts would not be rejected and, of course, there’s no donor to wait for.

“Among the next steps that we are pursuing are improving methods to generate even more cardiac cells,” said Jacques Guyette, a biomedical researcher at the MGH Center for Regenerative Medicine and lead author of the study, in a statement. Although this study manufactured a whopping 500 million stem cell-derived heart cells for the procedure, regrowing a whole heart would actually take “tens of billions,” Guyette added.

So despite falling short of growing an entire, mature human heart in a laboratory from a patient’s own cells, this is the closest anyone has come to date to reaching this goal – and that in itself is a breathtaking achievement.

Read full post

In other news, Cenk Uygur from The Young Turks talks to doctors Todd Evans, Jim Cheung and Albano Meli about stem cell research and how it can help in curing heart defects. Watch the incredibly fascinating interview:

For more information and free report, visit Neo Matrix Medical.



from Neo Matrix Medical http://ift.tt/2bJdoUs
via IFTTT

Wednesday, 27 July 2016

Stem Cell Therapy is Saving Lives, Canadian Doctors Treat Patient with Multiple Sclerosis

Stem cells have successfully been used to treat various blood related forms of cancer for years and now research has paved way for treatments that encompass a vast range of conditions – from Alzheimer’s and Parkinson’s to osteoarthritis, muscle degeneration, Crohn’s disease and multiple sclerosis, a debilitating disease. The most common procedure for stem cell therapy is bone marrow transplant but there is no shortage of alternative methods and new discoveries.

Employing latest research in stem cell therapy, doctors in Canada have been able to ‘cure’ a patient of multiple sclerosis. This is a promising advancement in stem cell research.

Erin Davis reports for Notable

Canadian doctors have managed to reverse severe MS using stem cells, virtually eliminating it from a patient’s body. Jennifer Molson had crippling MS before she participated in a study that involved chemotherapy and a stem cell bone marrow transplant in 2002. Molson was one of a small cohort of 24 people who received the high-risk, experimental therapy.

Led by Dr. Mark Freedman and Dr. Harold Atkins at the Ottawa Hospital, the clinical trial spanned over 13 years.

Of the patients, 70 per cent saw the progression of their disease halted or reversed as their symptoms began to diminish. While Molson could barely walk or feed herself pre-trial, she now drives, kayaks, runs and skis, and hasn’t experienced any symptoms of the disease for 14 years.

It’s been hailed as remarkable by industry professionals, as the trial seems to “cure” people of their symptoms.

The experience of the cohort was documented in a paper published this week in The Lancet. It’s being called the first to describe any MS treatment that fully stops the disease over the long-term without MS medication. “This is the first treatment to produce this level of disease control or neurological recovery” from MS, said The Lancet in a news release.

 

 

Sclerosis Progresses

MS affects 20 million people globally, but tends to target females in more temperate climates like Canada and the northern U.S.

The disease is characterized by an immune system that turns on the host and attacks the protective coating around the nerve fibres in the brain and spinal cord. These attacks can severely damage and destroy the nerves and protective coating, affecting the communication between the brain and the body and leading to symptoms like numbness, loss of balance, difficulty walking, loss of control of bowel and bladder, and even blindness.

Over time, patients lose control of their bodies and are often confined to wheelchairs.

Not all types of MS have the same affects. The least evil of the disease is “relapsing-remitting,” whereby the symptoms come and go and can be followed by long periods of remission. For most people, however, this version of the disease usually progresses into secondary progressive MS over time, whereby the symptoms start to stick. The most aggressive form of the disease is primary progressive MS. In this case, patients don’t experience bouts of remission, but rather a continuous decline in their health and a worsening of their symptoms.

At the time of her treatment, Molson had secondary progressive MS. Prior to the stem cell trials, nothing had worked to better her symptoms.

The treatment essentially involves an extensive combination of chemotherapy and stem cell transplants that are designed to reboot the immune system. It sees doctors harvest stem cells from the bone marrow of their patients, then purify and freeze the cells. Patients then undergo extensive chemotherapy before the preserved stem cells are returned to the patients.

sclerosis 2

The idea is to wipe clean and reset the immune system so it has no memory of attacking the central nervous system.

According to The Lancet, the procedure fully halted clinical relapses in all of the patients and stopped the development of any new brain lesions without any medication. Other stem cell transplants have resulted in positive short-term results in MS patients, but the symptoms always returned. What makes the Ottawa trial different is that, unlike previous trials what aimed to suppress the immune system, it wipes it out altogether.

While promising, the treatment is regarded as extremely high-risk, which places limitations on its widespread use. There are high mortality rates associated with the procedure; one patient out of the initial 24 involved in the clinical trial died from liver failure. It should also be highlighted that 30 per cent of the patients did see their symptoms worsen, likely because their MS was already too far along.

Only five per cent of MS patients are eligible for this type of treatment. But for those who are, it’s being called a ‘miracle treatment’ and The Lancet is urging more clinical trials.

sclerosis 3

You can read the original article here.

So how do stem cells do all that? How is it possible to treat such a wide array of conditions with these unspecialized cells?

Peter Diamandis from Singularity Hub explains:

You are a collection of over 30 trillion human cells.

Every one of these cells, those in your brain, lungs, liver, skin, and everywhere else, derives from a single pluripotent type of cell called a stem cell.

This post is about how stem cells are going to change medicine forever, extend life, and potentially save your life in the years ahead.

In this blog we’ll talk about why it’s important to bank the cells of your newborn children or grandchildren — and potentially your own (no matter how old you are).

In a recent Abundance 360 webinar, I had the chance to interview Dr. Robert (Bob) Hariri, one of the world’s foremost experts on stem cells. He’s the founder, chairman and chief science officer of Celgene Therapeutics, and the co-founder and vice-chairman of Human Longevity Inc. (HLI). Here is what we discussed.

What are stem cells?

Stem cells have the remarkable ability to “differentiate” into any other type of cell in the body.

Dr. Hariri explains, “At the beginning of life, a single nondescript cell with a giant nucleus, cytoplasm, and a cell membrane, goes on to replicate and create every cell in our body.

“This single cell contains within it the entire genetic code — the biological software — necessary to produce everything that ultimately defines each and every specialized cell type in the body.”

After our body has developed, among our tens of trillions of fully differentiated human cells (skin, heart, muscle, kidney) remain a population of quiescent stem cells waiting to be called into action to help repair damaged tissue. These stem cells reside everywhere: in our bone marrow, in our fat, and in every single tissue compartment.

And, as Dr. Hariri describes them, “they are nature’s perfect repair kit — ready to be mobilized and facilitate repair when needed.”

Read the full post here.

For a more visual explanation, watch this video

<iframe width=”560″ height=”315″ src=”https://www.youtube.com/embed/8JTw2RpDo9o” frameborder=”0″ allowfullscreen></iframe>

To know more about stem cell therapy, visit Neo Matrix.



from Neo Matrix Medical http://ift.tt/2auwqSo
via IFTTT